Showing results (3031-3040 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|January 25, 2013
Treatment of foot disease in patients with type 2 diabetes mellitus using human umbilical cord blood mesenchymal stem cells: response and correction of immunological anomaliesXiao-Yan Li, Zhao-Hui Zheng, Xue-Yi Li, et al.Current Pharmaceutical Design|January 25, 2013
Recent advances of diaryl ether family as HIV-1 non-nucleoside reverse transcriptase inhibitorsXuwang Chen, Shufang Ding, Peng Zhan, et al.Current Pharmaceutical Design|January 16, 2013
Colesevelam: a new and improved bile acid sequestrant?Konstantinos Tziomalos, Asterios Karagiannis, Dimitri P Mikhailidis, et al.Current Pharmaceutical Design|January 18, 2013
Functions of the third intracellular loop of the human melanocortin-3 receptorZhi-Qiang Wang, Ya-Xiong TaoCurrent Pharmaceutical Design|January 18, 2013
PPARγ activation improves the molecular and functional components of I(to) remodeling by angiotensin IIGayani Nanayakkara, Nilmini Viswaprakash, Juming Zhong, et al.Current Pharmaceutical Design|January 18, 2013
MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2Fan Fan, Aijun Sun, Hangtian Zhao, et al.Current Pharmaceutical Design|December 25, 2012
HIV-1 associated Topoisomerase IIβ kinase: a potential pharmacological target for viral replicationKannapiran Ponraj, Maddela Prabhakar, R S Rathore, et al.Current Pharmaceutical Design|December 25, 2012
Rational approaches towards lead optimization of kinase inhibitors: the issue of specificityPreethi Badrinarayan, G Narahari SastryCurrent Pharmaceutical Design|December 25, 2012
Approaches to virtual screening and screening library selectionScott A WildmanCurrent Pharmaceutical Design|December 29, 2012
Mechanisms, prevention and treatment of distal embolizationItalo Porto, Giovanni Luigi De Maria, Maurizio Pieroni, et al.Pageof 1,008